http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0139731-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-937 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-937 |
| filingDate | 1984-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cf93d6205cc6ebd813d55c9abece003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb7587a1a23b5049edea8184417123c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_186c9a341caf35ed6c11c719edfc5b7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b9d05fb4b598852a9b310752f43a5fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a079d6172a1fb1d237e73b48c4d11e63 |
| publicationDate | 1985-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0139731-A1 |
| titleOfInvention | 5-ethynyl-prostacyclyne, production process thereof and pharmaceutical utilisation thereof |
| abstract | 5-Ethinyl-prostacyclin derivatives of formula (I), where R1 represents a hydrogen, an alkyl, a cycloalkyl, an aryl, a heterocyclic residue or a group $ (4,) $, R2 represents a hydrogen atom in alpha or beta or a methyl group in alpha or beta, R3 represents an alkyl, cycloalkyl or aryl group optionally substituted, or a heterocyclic group, A represents a group -CH2-CH2-, -CH = CH- trans or -C = C-, B represents a straight chain alkene group having from 1 to 5 C atoms, D and E together form a direct bond or D represents a saturated straight chain alkene group having from 1 to 5 C atoms, an alkene group saturated with branched chain or unsaturated with straight chain comprising from 2 to 5 atoms of C which can, if necessary, be substituted by atoms of fluorine, E represents an oxygen atom, a group -C = C- or a group -CR4 = CR5-, where R4 and R5 are different from each other, may represent a hydrogen atom or an alkyl group comprising t from 1 to 3 C atoms and, if R1 represents a hydrogen atom, represent the physiologically acceptable salts of said compounds with organic or inorganic bases; their manufacturing process and their pharmaceutical use. |
| priorityDate | 1983-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.